REVA Medical Inc. To Focus on Breakthrough Scaffold: Fantom

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, March 27, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announced today that it has positioned the Company to fast-track the development of its breakthrough “thin-strut” fully bioresorbable scaffold family, Fantom.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC